These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8030173)

  • 1. Advanced prostatic carcinoma in a 19-year-old male.
    Jindal PK; Hota D; Prasad KV; Nijhawan R; Vaidyanathan S
    Urol Int; 1994; 52(4):225-7. PubMed ID: 8030173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined androgen blockade in the management of advanced prostate cancer: a sensible or ostensible approach.
    Ansari MS; Gupta NP; Hemal AK; Dogra PN; Seth A
    Int J Urol; 2004 Dec; 11(12):1092-6. PubMed ID: 15663681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience in advanced prostatic cancer: orchiectomy and flutamide versus orchiectomy and estramustine phosphate.
    Roessler W; Hinke A; Wieland WF
    Urology; 1994 Feb; 43(2 Suppl):57-60. PubMed ID: 8116134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostatic carcinoma presenting as an abdominal mass: a case report].
    Harada M; Tokuda N; Tsubaki H; Kase T; Tajima M; Sawamura Y; Matsushima M; Naoe S; Harada M
    Hinyokika Kiyo; 1992 Dec; 38(12):1399-402. PubMed ID: 1288230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prostatic carcinoma in a young adult: a case report].
    Yamamoto S; Senzaki A; Yamagiwa K; Tanaka T; Oda T
    Hinyokika Kiyo; 1990 May; 36(5):617-22. PubMed ID: 1698013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of advanced prostatic carcinoma with total androgenic blockade using bilateral orchidectomy and flutamide: experience at the National Cancer Institute in Mexico.
    Mendoza-Valdés A; Ocampo-del-Carpio O; De-la-Garza J
    Semin Oncol; 1991 Oct; 18(5 Suppl 6):19-20. PubMed ID: 1948118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of prostatic carcinoma in an advanced stage. Our experience].
    Dublino M; Lasaponara F; Rizzello N
    Minerva Urol Nefrol; 1992; 44(3):195-9. PubMed ID: 1492271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with flutamide and castration (orchiectomy or LH-RH agonist) in untreated patients with advanced prostate cancer.
    Dupont A; Labrie F; Cusan L; Gomez JL; Tremblay M; Lacourcière Y; Emond J; Monfette G
    Recent Results Cancer Res; 1992; 124():43-54. PubMed ID: 1615218
    [No Abstract]   [Full Text] [Related]  

  • 9. [Complete androgen blockade (orchiectomy + flutamide) versus androgen blockade with cytostasis (orchiectomy + estramustine) in the treatment of virginal advanced prostate cancer].
    Flamm J; Fischer M
    Wien Klin Wochenschr; 1988 Sep; 100(17):589-92. PubMed ID: 3055689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advanced carcinoma of the prostate (stages C and D). Mortality within 12 months of the initiation of hormonal therapy].
    Ferraris V; Vitale I; Pisano PF; Buffa G
    Minerva Urol Nefrol; 1992; 44(3):205-8. PubMed ID: 1492272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Does total androgen suppression in advanced prostatic cancer induce a greater number of complete remissions? A phase II trial].
    Germà Lluch JR; Izquierdo Delso MA; Seguí Palmer MA; Villavicencio H; Ojeda González B; de Andrés Basauri L; Pallarés Curto C
    Actas Urol Esp; 1991; 15(1):34-8. PubMed ID: 1905458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is flutamide effective in patients with bilateral orchiectomy?
    Rothman KJ; Johnson ES; Sugano DS
    Lancet; 1999 Apr; 353(9159):1184. PubMed ID: 10210003
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer.
    Labrie F; Dupont A; Giguère M; Borsanyi JP; Lacourciere Y; Bélanger A; Lachance R; Emond J; Monfette G
    Prog Clin Biol Res; 1988; 260():41-62. PubMed ID: 3283766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current management of prostatic carcinoma.
    Bahnson RR; Catalona WJ
    Prim Care; 1985 Dec; 12(4):795-813. PubMed ID: 3909178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bilateral testicular metastasis of an adenocarcinoma of the prostate].
    Giannakopoulos X; Bai M; Grammeniatis E; Stefanou D; Agnanti N
    Ann Urol (Paris); 1994; 28(5):274-6. PubMed ID: 7825987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What is safe in the therapy of advanced prostatic cancer?].
    Gropp C; Burk K
    Internist (Berl); 1985 Dec; 26(12):765-70. PubMed ID: 3936819
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen, and combination treatment with luteinizing hormone-releasing hormone agonist and flutamide.
    Moorjani S; Dupont A; Labrie F; Lupien PJ; Gagné C; Brun D; Giguère M; Bélanger A; Cusan L
    J Clin Endocrinol Metab; 1988 Feb; 66(2):314-22. PubMed ID: 3276721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Objective treatment response to endocrine therapy in metastatic prostate cancer.
    Zaragoza MR; Grossman HB
    Urology; 1992 Nov; 40(5):405-8. PubMed ID: 1441036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablation.
    Zagars GK; Pollack A; von Eschenbach AC
    Cancer; 1997 Aug; 80(4):764-75. PubMed ID: 9264361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.